Trial intelligence / Profile preview

Phenylbutyrate and Genistein for Cystic Fibrosis

NCT00016744Phase 2Completed

Sponsor
Children's Hospital of Philadelphia
Start
Sep 2001
Primary completion
Oct 2005
Modality
Orthosteric Ligands
01

Overview

A Phase 2 trial of sodium phenylbutyrate, genistein in cystic fibrosis (CF), sponsored by Children's Hospital of Philadelphia. Started Sep 2001; status: completed.

02

Drugs

sodium phenylbutyrategenistein
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT00016744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00016744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call